P Burra

Summary

Affiliation: University of Padova
Country: Italy

Publications

  1. ncbi Combined liver-kidney transplantation in a 15-year-old boy with alpha1-antitrypsin deficiency
    Massimiliano Loreno
    Department of Surgical and Gastroenterological Sciences, University of Padua, Via Giustiniani 2, 35122 Padua, Italy
    J Hepatol 36:565-8. 2002
  2. ncbi Sexual dysfunction after liver transplantation
    Patrizia Burra
    Gastroenterology, Multivisceral Transplant Unit, Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    Liver Transpl 15:S50-6. 2009
  3. ncbi Hepatitis C
    Patrizia Burra
    Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    Semin Liver Dis 29:53-65. 2009
  4. ncbi Influence of steroids on HCV recurrence after liver transplantation: A prospective study
    Marco Vivarelli
    Department of Surgery and Transplantation, University of Bologna, Italy
    J Hepatol 47:793-8. 2007
  5. ncbi Quality of life following organ transplantation
    Patrizia Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, Padua University, Padua, Italy
    Transpl Int 20:397-409. 2007
  6. ncbi Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes
    Patrizia Burra
    Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy
    J Hepatol 58:287-96. 2013
  7. ncbi Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury
    Patrizia Burra
    Gastroenterology, Department of Surgical, Oncological and Gastroenterological Sciences, Padova University Hospital, Via Giustiniani 2, Padova, 35128, Italy
    BMC Gastroenterol 12:88. 2012
  8. ncbi The adolescent and liver transplantation
    Patrizia Burra
    Multivisceral Transplant Unit, Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, Padova University Hospital, Padova, Italy
    J Hepatol 56:714-22. 2012
  9. ncbi A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
    Andreas A Schnitzbauer
    University Hospital Regensburg, Department of Surgery, Regensburg, Germany
    BMC Cancer 10:190. 2010
  10. ncbi Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients
    Patrizia Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    Liver Transpl 15:619-28. 2009

Detail Information

Publications100

  1. ncbi Combined liver-kidney transplantation in a 15-year-old boy with alpha1-antitrypsin deficiency
    Massimiliano Loreno
    Department of Surgical and Gastroenterological Sciences, University of Padua, Via Giustiniani 2, 35122 Padua, Italy
    J Hepatol 36:565-8. 2002
    ....
  2. ncbi Sexual dysfunction after liver transplantation
    Patrizia Burra
    Gastroenterology, Multivisceral Transplant Unit, Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    Liver Transpl 15:S50-6. 2009
    ..5. More detailed and comprehensive data are needed in the field of sexual function after transplantation, and new strategies are needed to support and inform patients on the waiting list and after liver transplantation...
  3. ncbi Hepatitis C
    Patrizia Burra
    Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    Semin Liver Dis 29:53-65. 2009
    ..We must be prepared for the fact that increasing numbers of HCV-positive recipients with allografts failing due to recurrent HCV will be asking to be retransplanted-and we do not know yet how to respond to this request...
  4. ncbi Influence of steroids on HCV recurrence after liver transplantation: A prospective study
    Marco Vivarelli
    Department of Surgery and Transplantation, University of Bologna, Italy
    J Hepatol 47:793-8. 2007
    ..To assess the effect of long-term maintenance of steroids on HCV recurrence after liver transplantation (LT), that is still controversial, a prospective multicentre trial was conducted at the centres of Bologna and Padua, Italy...
  5. ncbi Quality of life following organ transplantation
    Patrizia Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, Padua University, Padua, Italy
    Transpl Int 20:397-409. 2007
    ..g. sexual function, pregnancy, schooling, sport and work...
  6. ncbi Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes
    Patrizia Burra
    Multivisceral Transplant Unit, Department of Surgery, Oncology and Gastroenterology, Padova University Hospital, Padova, Italy
    J Hepatol 58:287-96. 2013
    ..HBV-related chronic liver disease is one of the most common indications for liver transplantation (LT) in Europe. The ELTR database was used to evaluate outcomes and evolution over 20 years (01/1988 and 12/2010)...
  7. ncbi Systemic administration of a novel human umbilical cord mesenchymal stem cells population accelerates the resolution of acute liver injury
    Patrizia Burra
    Gastroenterology, Department of Surgical, Oncological and Gastroenterological Sciences, Padova University Hospital, Via Giustiniani 2, Padova, 35128, Italy
    BMC Gastroenterol 12:88. 2012
    ..We aimed to evaluate the therapeutic potential of mesenchymal stem cells from human umbilical cord (UCMSCs), a readily available source of mesenchymal stem cells, in the CCl4-induced acute liver injury model...
  8. ncbi The adolescent and liver transplantation
    Patrizia Burra
    Multivisceral Transplant Unit, Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, Padova University Hospital, Padova, Italy
    J Hepatol 56:714-22. 2012
    ..Non-adherence is associated with a poor medical outcome. Both physical and psychosocial functioning is reportedly lower among young liver transplant recipients than in the general population...
  9. ncbi A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma
    Andreas A Schnitzbauer
    University Hospital Regensburg, Department of Surgery, Regensburg, Germany
    BMC Cancer 10:190. 2010
    ..Therefore, we designed a prospective RCT to determine if the mTOR inhibitor sirolimus can improve hepatocellular carcinoma (HCC)-free patient survival in liver transplant (LT) recipients with a pre-transplant diagnosis of HCC...
  10. ncbi Donor livers with steatosis are safe to use in hepatitis C virus-positive recipients
    Patrizia Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    Liver Transpl 15:619-28. 2009
    ..Steatotic grafts do not seem to exacerbate the progression of fibrosis in HCV+ recipients, nor do they seem to negatively affect 3-year patient survival...
  11. ncbi Liver transplantation for alcoholic liver disease in Europe: a study from the ELTR (European Liver Transplant Registry)
    P Burra
    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University Hospital of Padova, Padova, Italy
    Am J Transplant 10:138-48. 2010
    ..Screening for de novo tumors and prevention of cardiovascular complications are essential to provide better long-term results...
  12. ncbi Longitudinal prospective study on quality of life and psychological distress before and one year after liver transplantation
    P Burra
    Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    Acta Gastroenterol Belg 68:19-25. 2005
    ..The impact of liver disease and medical complications on quality of life (QOL) and psychological distress before and after liver transplantation (LT) is a matter of growing interest...
  13. ncbi Strategies for liver support: from stem cells to xenotransplantation
    Patrizia Burra
    Department of Surgical and Gastroenterological Sciences, University Hospital, Padova, Italy
    J Hepatol 41:1050-9. 2004
  14. ncbi Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study
    P Burra
    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University Hospital Padova, Padova, Italy
    Dig Liver Dis 41:350-6. 2009
    ..Given organ shortage it should be essential to determine which patients will experience progressive and severe renal dysfunction after liver transplantation (LT)...
  15. ncbi Torque Teno Virus: any pathological role in liver transplanted patients?
    Patrizia Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    Transpl Int 21:972-9. 2008
    ..On the basis of our data, TTV does not seem to cause liver damage following LT, although larger studies with a long-term follow up are needed to confirm these findings...
  16. ncbi HCV infection in haemodialysed patients: a role for serum IL-10 and TGF-beta1 in liver damage?
    P Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, University of Padova, Via Giustiniani 2, 35128 Padova, Italy
    Dig Liver Dis 40:827-33. 2008
    ..IL-10 and TGF-beta1 could play a role in this setting as, IL-10 down-regulates hepatic fibrosis, while TGF-beta1 is a pro-fibrotic cytokine...
  17. ncbi Experimental hepatology applied to stem cells
    P Burra
    Department of Surgical and Gastroenterological Sciences, University of Padua, Italy
    Dig Liver Dis 40:54-61. 2008
    ..The fact that numerous specialties were represented helped the audience to understand the stem cell research area from different standpoints, and what research has achieved so far...
  18. ncbi The concept of quality of life in organ transplantation
    P Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, Padua University, and Gastroenterology Unit, Feltre, Italy
    Transplant Proc 39:2285-7. 2007
    ....
  19. ncbi Antiviral therapy for hepatitis C virus recurrence following liver transplantation: long-term results from a single center experience
    P Burra
    Department of Surgical and Gastroenterological Sciences, University Hospital, Padova, Italy
    Transplant Proc 38:1127-30. 2006
    ..This study aimed to assess the safety and efficacy of alpha-interferon (IFN) plus ribavirin for recurrent HCV following liver transplantation...
  20. ncbi Should donors and recipients be matched in liver transplantation?
    Patrizia Burra
    Division of Gastroenterology, Department of Surgical and Gastroenterological Sciences, Padova University Hospital, Padova, Italy
    J Hepatol 45:488-94. 2006
  21. ncbi Liver transplantation in alcoholic patients
    Patrizia Burra
    Section of Gastroenterology, Liver Gastroenterology Transplantation, Department of Surgical and Gastroenterological Sciences, University Hospital, University of the Study, Padua, Italy
    Transpl Int 18:491-8. 2005
    ....
  22. ncbi Does liver-disease aetiology have a role in cerebral blood-flow alterations in liver cirrhosis?
    P Burra
    Gastroenterology and Surgery, Department of Surgical and Gastroenterological Sciences, University of Padua, Italy
    Eur J Gastroenterol Hepatol 16:885-90. 2004
    ..Studies using brain-imaging techniques have shown changes in regional blood flow (rCBF) in patients with liver cirrhosis. It remains unknown whether the aetiology of liver disease accounts for these changes...
  23. ncbi Therapeutic application of stem cells in gastroenterology: an up-date
    Patrizia Burra
    Department of Surgical and Gastroenterological Sciences, Gastroenterology Section, University of Padua, 35128 Padova, Italy
    World J Gastroenterol 17:3870-80. 2011
    ..Here, we report on the issues discussed, including liver and intestinal diseases that may benefit from stem cell therapy, the biology of hepatic and intestinal tissue repair, and stem cell usage in clinical trials...
  24. ncbi Warm hepatic ischemia in pigs: effects of L-arginine and oligotide treatment
    P Burra
    Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Universita degli Studi di Padova, Italy
    J Invest Surg 14:303-12. 2001
    ..The increased plasma levels of nitric oxide a week after ischemia-reperfusion injury support the hypothesis that it has a role in preventing liver damage. The same beneficial effect was not confirmed for oligotide...
  25. ncbi Frontal cerebral blood flow is impaired in patients with heart transplantation
    Patrizia Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, University of Padua, Via Giustiniani 2, Italy
    Transpl Int 15:459-62. 2002
    ....
  26. ncbi Occurrence of post-transplant lymphoproliferative disorders among over thousand adult recipients: any role for hepatitis C infection?
    Patrizia Burra
    Department of Surgical and Gastroenterological Sciences, University of Padua, Padua Italy
    Eur J Gastroenterol Hepatol 18:1065-70. 2006
    ..Hepatitis C virus may induce clonal expansion of B-lymphocytes and has been associated with extrahepatic lymphoproliferative disorders...
  27. ncbi Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus
    P Burra
    Multivisceral Transplant Unit, Gastroenterology, Padova University, Padova Italy
    Transplant Proc 43:2455-6. 2011
    ..Therefore, antiviral treatment appears to be recommended for patients infected with HCV. This article reviewed recent evidence on antiviral therapy for HCV-infected patients...
  28. ncbi Sexual dysfunction in chronic liver disease: is liver transplantation an effective cure?
    Patrizia Burra
    Department of Surgical and Gastroenterological Sciences, Multivisceral Transplant Unit, Gastroenterology, University of Padova, Padova, Italy
    Transplantation 89:1425-9. 2010
    ..Further studies on pathophysiology and risk factors in the field of sexual function after liver transplantation along with new strategies to support and inform patients on the waiting list and after surgery are needed...
  29. ncbi Adherence in liver transplant recipients
    Patrizia Burra
    Gastroenterology, Multivisceral Transplant Unit, Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    Liver Transpl 17:760-70. 2011
    ..Patients have been split into 2 age groups (adults and children/adolescents) because the scale of the problem and the potential risk factors differ in the 2 groups...
  30. ncbi Donor-Model for End-Stage Liver Disease and donor-recipient matching in liver transplantation
    A Vitale
    Unità di Chirurgia Epatobiliare e Trapianto Epatico, Azienda Università di Padova, Padova, Italy
    Transplant Proc 43:974-6. 2011
    ..The aim of this study was to evaluate the prognostic ability of D-MELD among a cohort of Italian patients already selected for LT on the basis of a D-R matching philosophy...
  31. ncbi Risk factors in liver retransplantation: a single-center experience
    C Crivellin
    Multivisceral Transplant Unit, Department of Surgical and Gastroenterological Sciences, University Hospital of Padua, Padua, Italy
    Transplant Proc 43:1110-3. 2011
    ..Forty percent of deaths after Re-OLT occurred among HCV(+) recipients, but for reasons unrelated to HCV infection...
  32. ncbi HCV histological recurrence and survival following liver transplantation in patients with and without hepatocellular carcinoma
    E De Martin
    Department of Surgical and Gastroenterological Sciences, Gastroenterology, Padova University, Padova, Italy
    Transplant Proc 40:1974-5. 2008
    ..HCV recurrence after LT is universal. This study evaluated HCV recurrence and survival in patients transplanted for HCV and HCC...
  33. ncbi Fibrosis progression and the pros and cons of antiviral therapy for hepatitis C virus recurrence after liver transplantation: a review
    E De Martin
    Gastroenterology, Multivisceral Transplant Unit, Department of Surgical and Gastroenterological Sciences, Padua University, Padua, Italy
    Transplant Proc 42:2223-5. 2010
    ..In conclusion, the donor- recipient match should be assessed to limit HCV recurrences and their severity; AT is recommended to reduce or reverse the progression of fibrosis...
  34. ncbi Estimation of the harm to the waiting list as a crucial factor in the selection of patients with hepatocellular carcinoma for liver transplantation
    A Vitale
    Unità di Chirurgia Epatobiliare e Trapianto Epatico, Azienda Università di Padova, Padova, Italy
    Transplant Proc 42:1194-6. 2010
    ..The aim of this study was to evaluate the minimum post-OLT survival threshold that would justify the selection of a patient with HCC for OLT...
  35. ncbi Long-term medical and psycho-social evaluation of patients undergoing orthotopic liver transplantation for alcoholic liver disease
    P Burra
    Gastroenterology Unit, University Hospital, Padua, Italy
    Transpl Int 13:S174-8. 2000
    ..A multidisciplinary approach evaluating medical and psycho-social variables before OLT and a close follow up after OLT are mandatory for ALD patients...
  36. ncbi Histological features after liver transplantation in alcoholic cirrhotics
    P Burra
    Department of Surgical and Gastroenterological Sciences, University of Padova, University Hospital, Italy
    J Hepatol 34:716-22. 2001
    ..This study aims to evaluate the effect of alcohol recidivism on survival rates and histological parameters in patients transplanted for alcoholic cirrhosis, with and without hepatitis C virus (HCV) infection...
  37. ncbi HBV and HCV infections in heart transplant recipients
    S Fagiuoli
    Department of Surgical and Gastroenterological Sciences, University of Padova, Padova, Italy
    J Heart Lung Transplant 20:718-24. 2001
    ..The aim of the present study was to define the prevalence, clinical features, and natural history of HBV and HCV infections in a cohort of HTx recipients...
  38. ncbi Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients
    A W Avolio
    General Surgery and Transplantation Unit, Department of Surgery, A Gemelli Hospital, Catholic University, Rome, Italy
    Am J Transplant 11:2724-36. 2011
    ..The 5yrsPS<50% cutoff was identified only in HCV patients (D-MELD ≥ 1750). The innovative approach offered by D-MELD and covariates is helpful in predicting outcome after liver transplantation, especially in HCV recipients...
  39. ncbi Algorithm for prioritization of patients on the waiting list for liver transplantation
    M Gambato
    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    Transplant Proc 39:1855-6. 2007
    ..Prioritization of patients on the waiting list (WL) for OLT is still a critical issue. Numerous models have been developed to predict mortality before and after OLT...
  40. ncbi Combined liver and kidney transplantation: analysis of Padova experience
    G Zanus
    Department of Surgical and Gastroenterological Science, University of Padova, Padova, Italy
    Transplant Proc 39:1933-5. 2007
    ..The aim of this study was to evaluate our results with CLKT both in adult and pediatric patients...
  41. ncbi Alcohol abuse and de novo tumors in liver transplantation
    G Zanus
    Hepatobiliary and Liver Transplant Unit, Department of General Surgery and Organ Transplant, University of Padua, Padua, Italy
    Transplant Proc 41:1310-2. 2009
    ..Organ transplant recipients show an increased incidence of cancer ranging from 4% to 16% owing to several causes: immunosuppression, viral infection, individual predisposition, and so on...
  42. ncbi Validation of the BCLC prognostic system in surgical hepatocellular cancer patients
    A Vitale
    Unità di Chirurgia Oncologica, Istituto Oncologico Veneto, IRCCS, Padova, Italy
    Transplant Proc 41:1260-3. 2009
    ..The aim of this study was to investigate the value of known prognostic systems in 400 Italian HCC patients treated with radical surgical therapies...
  43. ncbi Sorafenib for the treatment of recurrent hepatocellular carcinoma after liver transplantation?
    A Vitale
    Unità di Chirurgia Epatobiliare e Trapianto Epatico, Azienda Università di Padova, Padova, Italy
    Transplant Proc 44:1989-91. 2012
    ..There are scarce data on the use of sorafenib for the treatment of recurrent hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT)...
  44. ncbi Hepatitis C virus: from oxygen free radicals to hepatocellular carcinoma
    F Farinati
    Dipartimento di Scienze Chirurgiche e Gastroenterologiche, Sezione di Gastroenterologia, Policlinico Universitario, Universita di Padova, Padova, Italy
    J Viral Hepat 14:821-9. 2007
    ....
  45. ncbi Neuropsychological and neurophysiological evaluation in cirrhotic patients with minimal hepatic encephalopathy undergoing liver transplantation
    M Senzolo
    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University-Hospital of Padua, Italy
    Transplant Proc 37:1104-7. 2005
    ....
  46. ncbi Nonadherent behaviors after solid organ transplantation
    G Germani
    Gastroenterology Department of Surgical and Gastroenterological Sciences, Padua University Hospital, Padova, Italy
    Transplant Proc 43:318-23. 2011
    ..The aim of this study was to assess, among patients who underwent solid organ transplantation, nonadherent behaviors (NAB) to immunosuppressive therapy, to correct lifestyle, and to general medical prescriptions...
  47. ncbi Microwave thermal ablation for hepatocarcinoma: six liver transplantation cases
    G Zanus
    General Surgery and Organ Transplantation, Hepatobiliary Surgery and Liver Transplant Unit, Azienda Università di Padova, Padova, Italy
    Transplant Proc 43:1091-4. 2011
    ..In conclusion, a MWA seemed to be a safe novel approach to treat HCC and could serve as a "bridge" to OLT and down-staging for patients with HCC...
  48. ncbi Adjuvant chemotherapy for transplanted hepatocellular carcinoma patients: impact on survival or HCV recurrence timing
    M Bassanello
    Clinica Chirurgica 1 and Liver Transplantation Unit, Department of Surgical and Gastroenterological Sciences, Padua University, P G Cevese University Hospital, Via Giustiniani 2, Padua 35128, Italy
    Transplant Proc 35:2991-4. 2003
    ..Liver transplantation (OLTx) represents a radical treatment for HCC and the underlying cirrhosis. Whether adjuvant chemotherapy is indicated in the postoperative period to prevent recurrence is controversial...
  49. ncbi Changing attitude to organ donation and transplantation in university students during the years of medical school in Italy
    P Burra
    Department of Surgical and Gastroenterological Science University Hospital of Padua, Padua, Italy
    Transplant Proc 37:547-50. 2005
    ..In conclusion, medical student attitudes to organ donation and transplantation are highly positive, but do not improve during the first 3 years of Medical School. An educational program is therefore needed...
  50. ncbi Bone metabolism and gonad function in male patients undergoing liver transplantation: a two-year longitudinal study
    A Floreani
    Department of Surgical and Gastroenterological Sciences, University of Padua, Italy
    Osteoporos Int 12:749-54. 2001
    ..Thus a high proportion of men with end-stage liver disease do have osteoporosis. After OLTx, an early recovery of gonad function is observed, followed by an increase in bone mass, which occurs from the sixth month onward...
  51. ncbi Progression of hepatocellular carcinoma before liver transplantation: dropout or liver transplantation?
    A Vitale
    Unità di Chirurgia Oncologica, Istituto Oncologico Veneto, IRCCS, Azienda Ospedaliera Universita di Padova, Padova, Italy
    Transplant Proc 41:1264-7. 2009
    ..The aim of this study was to show a correlation between adopted dropout criteria and dropout/intention-to-treat survival rates of WL HCC patients...
  52. ncbi Functional and morphological graft monitoring after liver transplantation
    F P Russo
    Department of Surgical and Gastroenterological Sciences, Gastroenterology Section, University of Padua, 35128, Padua, Italy
    Clin Chim Acta 310:17-23. 2001
    ..Liver biopsy is usually performed before the implantation of the graft to assess the viability of the liver and following liver transplantation, whenever clinical events warrant it or as part of a routine biopsy schedule...
  53. ncbi Post-transplant lymphoproliferative disorders after heart or kidney transplantation at a single centre: presentation and response to treatment
    S M L Aversa
    Division of Medical Oncology, Istituto Oncologico Veneto, IRCCS, Padua, Italy
    Acta Haematol 120:36-46. 2008
    ..Moreover, 4 second neoplasms were observed in the chemotherapeutic group. In this study, we demonstrated that most PTLD need other treatment than RI and a weekly regimen is manageable and has a favourable impact on long-term survival...
  54. ncbi Physiological and clinical implications of proANP(1-98) circulating levels in the perioperative phase of liver transplantation
    U Cillo
    Department of Surgical and Gastroenterological Sciences, Clinica Chirurgica 1, University of Padua, Padua, Italy
    Clin Chim Acta 310:39-48. 2001
    ..03). CONCLUSIONS: ANP(1-98) values may represent a useful marker of hemodynamic derangements during and after OLTx. Further clinical correlations will need a larger patient basis...
  55. ncbi Prospective validation of a new priority allocation model for liver transplant candidates: an interim analysis
    A Vitale
    Unità di Chirurgia Epatobiliare e Trapianto Epatico, Dipartimento di Chirurgia Generale e Trapianti d Organo, Azienda Ospedaliera Universita di Padova, Padova, Italy
    Transplant Proc 41:1092-5. 2009
    ..We sought to prospectively validate a priority allocation model that is believed to achieve objectivity without penalizing dropout risk and post-OLT results...
  56. ncbi Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma
    Umberto Cillo
    Unità di chirurgia epatobiliare e trapianto di fegato, Dipartimento assistenziale di chirurgia generale e trapianti d organo, University of Padua, School of Medicine, Padova, Italy
    J Surg Oncol 95:213-20. 2007
    ..Partial hepatectomy (PH) and liver transplantation (LT) compete as first-line treatment for hepatocellular carcinoma (HCC). A prospectively collected database was retrospectively reviewed to establish when PH can compete with LT...
  57. ncbi ABO blood group-related waiting list disparities in liver transplant candidates: effect of the MELD adoption
    Michele Barone
    Section of Gastroenterology, D E T O, University of Bari, Piazza G Cesare, Bari, Italy
    Transplantation 85:844-9. 2008
    ....
  58. ncbi Microvascular autonomic dysfunction may justify false-positive stress myocardial perfusion imaging in patients with liver cirrhosis undergoing liver transplantation
    M Senzolo
    Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    Transplant Proc 40:1916-7. 2008
    ..The aim of this study was to prospectively investigate the usefulness of an integrated cardiological approach in cirrhotic patients undergoing liver transplantation...
  59. ncbi Prognostic evaluation of the donor risk index among a prospective cohort of Italian patients undergoing liver transplantation
    A Vitale
    Unità di Chirurgia Oncologica, Istituto Oncologico Veneto, IRCCS, Padova, Italy
    Transplant Proc 41:1096-8. 2009
    ..The aim of this study was to prospectively evaluate the prognostic ability of DRI among a cohort of Italian patients undergoing OLT...
  60. ncbi Long-term evaluation of cognitive function and cerebral metabolism in liver transplanted patients
    M Senzolo
    Department of Surgical and Gastroenterological Sciences, University Hospital of Padua, Padua, Italy
    Transplant Proc 41:1295-6. 2009
    ....
  61. ncbi Bax inhibitor-1 down-regulation in the progression of chronic liver diseases
    Andromachi Kotsafti
    Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    BMC Gastroenterol 10:35. 2010
    ....
  62. ncbi Comparison between nifedipine and carvedilol in the treatment of de novo arterial hypertension after liver transplantation: preliminary results of a controlled clinical trial
    A Galioto
    Department of Clinical and Experimental Medicine, University of Padua, Padova, Italy
    Transplant Proc 37:1245-7. 2005
    ..Two of the nine nonresponders to nifedipine responded to carvedilol. The efficacy of monotherapy was observed in 11 of 40 randomized patients (27.5%). Carvedilol monotherapy is as effective as nifedipine but far better tolerated...
  63. ncbi Is osteoporosis a peculiar association with primary biliary cirrhosis?
    Annarosa Floreani
    Div Gastroenterologia, Via Giustiniani, 2, Padova 35128, Italy
    World J Gastroenterol 11:5347-50. 2005
    ....
  64. ncbi The critical issue of hepatocellular carcinoma prognostic classification: which is the best tool available?
    Umberto Cillo
    Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padua, School of Medicine, Via Giustiniani 2, 35128 Padua, Italy
    J Hepatol 40:124-31. 2004
    ..We investigated the value of known prognostic systems in the particular setting of a surgically oriented Liver Unit where 187 HCC Italian patients were mainly treated with radical therapies (resection and percutaneous ablation)...
  65. ncbi Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis B in the graft
    Massimiliano Loreno
    Department of Surgical and Gastroenterological Sciences, University of Padua, Via Giustiniani 2, 35128, Padua, Italy
    Transpl Int 17:730-4. 2005
    ..The course of gestation was uneventful and caesarean section was performed after 36 weeks. The newborn infant was a healthy male weighing 3,080 g and measuring 50 cm...
  66. ncbi Use of sorafenib in patients with hepatocellular carcinoma before liver transplantation: a cost-benefit analysis while awaiting data on sorafenib safety
    Alessandro Vitale
    Unità di Chirurgia Oncologica, Istituto Oncologico Veneto, IRCCS, Padova, Italy
    Hepatology 51:165-73. 2010
    ..CONCLUSION: Sorafenib neoadjuvant therapy is cost-effective by comparison with no therapy for T2-HCC patients waiting for LT, particularly for median times to LT under 6 months...
  67. ncbi Response to therapy as a criterion for awarding priority to patients with hepatocellular carcinoma awaiting liver transplantation
    Alessandro Vitale
    Unità di Chirurgia Oncologica, Istituto Oncologico Veneto, IRCCS, Padova, Italy
    Ann Surg Oncol 17:2290-302. 2010
    ..This study was designed to assess the effectiveness of a policy for prioritizing HCC patients according to their response to pre-LT therapy...
  68. ncbi The survival benefit of liver transplantation in hepatocellular carcinoma patients
    Umberto Cillo
    Unità di Chirurgia Epatobiliare e Trapianto Epatico, Azienda Ospedaliera Universita di Padova, Via Giustiniani 2, 35128 Padova, Italy
    Dig Liver Dis 42:642-9. 2010
    ..There are no studies evaluating the survival benefit of liver transplantation over alternative therapies for patients with hepatocellular carcinoma...
  69. ncbi Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma
    Umberto Cillo
    Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterlogiche, Italy
    Ann Surg 239:150-9. 2004
    ..To determine the long-term results of liver transplantation for well- or moderately differentiated hepatocellular carcinoma (HCC)...
  70. ncbi People's attitude toward xenotransplantation: affective reactions and the influence of the evaluation context
    Enrico Rubaltelli
    Department of Developmental and Socialization Psychology, University of Padua, Via Venezia 8, Padua, Italy
    Xenotransplantation 16:129-34. 2009
    ..human vs. pig donors) are presented together allowing people to compare among them (joint evaluation) and two conditions in which people are presented with only one of the two alternatives and cannot compare them (separate evaluation)...
  71. ncbi Transcatheter arterial chemoembolization (TACE) in hepatocellular carcinoma (HCC): the role of angiogenesis and invasiveness
    Adriana Sergio
    Istituto Oncologico Veneto, Padova, Italy
    Am J Gastroenterol 103:914-21. 2008
    ....
  72. ncbi A randomized study comparing ligation with propranolol for primary prophylaxis of variceal bleeding in candidates for liver transplantation
    Lorenzo Norberto
    Department of Surgical and Gastroenterological Sciences, 1st Surgical Clinic, Surgical Endoscopy Unit, University of Padova, Padova, Italy
    Liver Transpl 13:1272-8. 2007
    ..Our results suggest that banding should not be utilized as primary prophylaxis in transplant candidates who can be treated with BB...
  73. ncbi CD105(+) cells from Wharton's jelly show in vitro and in vivo myogenic differentiative potential
    Maria Teresa Conconi
    Department of Pharmaceutical Sciences, Cittadella Hospital, University of Padua, I 35131 Padua, Italy
    Int J Mol Med 18:1089-96. 2006
    ..These observations provide the first demonstration that CD105(+)/CD31(-)/KDR(-) cells are able not only to differentiate in vivo towards the myogenic lineage, but also to contribute to the muscle regenerative process...
  74. ncbi Strengthening acceptance for xenotransplantation: the case of attraction effect
    Enrico Rubaltelli
    Department of Developmental and Socialization Psychology, University of Padova, Padova, Italy
    Xenotransplantation 15:159-63. 2008
    ....
  75. ncbi Clinical significance of alpha-fetoprotein mRNA in blood of patients with hepatocellular carcinoma
    Umberto Cillo
    Clinica Chirurgica I, Department of Surgical and Gastroenterological Sciences, University of Padua, School of Medicine, Via Giustiniani 2, Policlinico III Piano, 35128 Padova, Italy
    Clin Chim Acta 347:129-38. 2004
    ....
  76. ncbi Protocol liver biopsies in long-term management of patients transplanted for hepatitis B-related liver disease
    Stefano Targhetta
    Department of Surgical and Gastroenterological Sciences, Gastroenterology Section, University Hospital, University of Padua, Via Giustiniani 2, 35128 Padua, Italy
    World J Gastroenterol 12:1706-12. 2006
    ..CONCLUSION: Though protocol biopsies may enable the detection of graft dysfunction at an early stage, the risk of progression and the clinical significance of these findings remains to be determined...
  77. ncbi Liver transplantation in Italy: current status. Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (A.I.S.F.)
    P Burra
    Chair of Gastroenterology, University of Padua, Italy
    Dig Liver Dis 32:249-56. 2000
    ..The multidisciplinary Study Group on Liver Transplantation of the Italian Association for the Study of the Liver (AISF) has collected information from all the Italian centres to ascertain the degree of consistency in their methods...
  78. ncbi Dynamic tests to study liver function
    P Burra
    Gastroenterology Section, Department of Surgical and Gastroenterological Sciences, University of Padova, Italy
    Eur Rev Med Pharmacol Sci 8:19-21. 2004
    ..They are more complex to perform and more expensive than conventional biochemical tests, but superior in monitoring the degree of liver dysfunction...
  79. ncbi New insights into the coagulopathy of liver disease and liver transplantation
    M Senzolo
    Department of Surgical and Gastroenterological Sciences, University Hospital of Padua, Padua, Italy
    World J Gastroenterol 12:7725-36. 2006
    ..During liver transplantation haemorrage may occur due to the pre-existing hypocoagulable state, the collateral circulation caused by portal hypertension and increased fibrinolysis which occurs during this surgery...
  80. ncbi Isoniazid-related fulminant hepatic failure in a child: assessment of the native liver's early regeneration after auxiliary partial orthotopic liver transplantation
    Umberto Cillo
    Clinica Chirurgica no. 1, Department of Surgical and Gastroenterological Sciences, University of Padua School of Medicine, Via Giustiniani 2, Policlinico III Piano, 35128, Padua, Italy
    Transpl Int 17:713-6. 2005
    ..In fact, the histological picture in this particular case may suggest the potential for NL recovery after INH-related FHF...
  81. ncbi Understanding of and attitudes to organ donation and transplantation: a survey among Italian university students
    Daniele Canova
    Department of Surgical and Gastroenterological Sciences, Padua University, Padova, Italy
    Clin Transplant 20:307-12. 2006
    ..Italian university students have a very positive attitude and willingness to donate their own organs after death, with no differences emerging as regards type of university education...
  82. ncbi Understanding of and attitude to xenotransplantation among Italian university students: impact of a 3-yr university course
    Daniele Canova
    Department of Surgical and Gastroenterological Sciences, Padua University, Padua, Italy
    Xenotransplantation 13:264-71. 2006
    ..Approval of xenotransplantation was much the same among fourth year males and females, whereas in the first year, male students had approved more than female students...
  83. ncbi Understanding of and attitudes to xenotransplantation: a survey among Italian university students
    Manuela De Bona
    Department of Surgical and Gastroenterological Sciences, Padua University, Padua, Italy
    Xenotransplantation 11:133-40. 2004
    ..The choice of a science rather than an arts faculty at university was more strongly associated with a positive opinion on xenotransplantation...
  84. ncbi Metabolic activity of rat hepatocytes cultured on homologous acellular matrix and transplanted into Gunn rats
    Silvia Tomat
    Department of Surgical and Gastroenterological Sciences, University of Padua, I-35121 Padua, Italy
    Int J Mol Med 18:837-42. 2006
    ..It is concluded that hepatocytes seeded on HAM and transplanted into Gunn rats are able to metabolize bilirubin for at least two months, without signs of rejection even in the absence of immunosuppressive therapy...
  85. ncbi Acellular liver matrix improves the survival and functions of isolated rat hepatocytes cultured in vitro
    Patrizia Burra
    Department of Surgical and Gastroenterological Sciences, Section of Gastroenterology, University of Padua, Via Gabelli 65, I-35121 Padua, Italy
    Int J Mol Med 14:511-5. 2004
    ..Taken together, these findings indicate that HAM strongly improves viability and functional activity of rat hepatocytes cultured in vitro...
  86. ncbi Study of the microcirculation in hDAF transgenic rat livers xenoperfused with human blood
    Silvia Tomat
    Department of Surgical and Gastroenterological Sciences, University of Padua, Via Giustiniani 2, VI piano Monoblocco, Padua, Italy
    Xenotransplantation 16:83-90. 2009
    ....
  87. ncbi Micronuclei and broken eggs in human liver carcinogenesis
    Maria Guido
    Department of Diagnostic Medical Sciences and Special Therapies, Pathology Unit, Universita degli Studi di Padova, Italy
    Anticancer Res 28:2507-11. 2008
    ..MNi/BE formation may result in activation of the p53-mediated cell cycle checkpoint...
  88. ncbi Neurologic complications after solid organ transplantation
    Marco Senzolo
    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University Hospital of Padua, Padua, Italy
    Transpl Int 22:269-78. 2009
    ....
  89. ncbi Growth hormone/insulin-like growth factor 1 axis recovery after liver transplantation: a preliminary prospective study
    Marco Bassanello
    Clinica Chirurgica I, Dipartimento di Scienze Chirurgiche e Gastroenterologiche, University of Padua, School of Medicine, Padua, Italy
    Liver Transpl 10:692-8. 2004
    ..Such a quick, postoperative modulation of IGF-1 plasma level by the graft suggests that this hormone has the potential to become one of the early indicators of post-OLT liver function recovery...
  90. ncbi Different neurological outcome of liver transplantation for Wilson's disease in two homozygotic twins
    Marco Senzolo
    Gastroenterology, Department of Surgical and Gastroenterological Sciences, University of Padua, Padua, Italy
    Clin Neurol Neurosurg 109:71-5. 2007
    ..The presence of neurological clinical manifestations in Wilson's disease should recommend caution indicating liver transplantation, because irreversible brain damage may exist...
  91. ncbi Effect of penicillamine and zinc on iron metabolism in Wilson's disease
    Valentina Medici
    Department of Surgical and Gastroenterological Sciences, Section of Gastroenterology, University of Padua, Padua, Italy
    Scand J Gastroenterol 42:1495-500. 2007
    ..The purpose of this study was to assess the iron metabolism parameters, including hepatic iron concentration, in follow-up liver biopsies and serum, and urinary pro-hepcidin...
  92. ncbi Risk of cancer following immunosuppression in organ transplant recipients and in HIV-positive individuals in southern Europe
    Diego Serraino
    Unita di Epidemiologia e Biostatistica, Centro di Riferimento Oncologico, Via F Gallini, 2, 33081 Aviano PN, Italy
    Eur J Cancer 43:2117-23. 2007
    ..8), and of borderline statistical significance in HIV-positive people (95% CI:0.9-2.8). Immune depression entails a two-fold increased overall risk of cancers, mainly related to cancers associated with a viral aetiology...
  93. ncbi Double-blind comparison of hepatitis C histological recurrence Rate in HCV+ Liver transplant recipients given basiliximab + steroids or basiliximab + placebo, in addition to cyclosporine and azathioprine
    Franco Filipponi
    Liver Transplantation Unit, University of Pisa, Hospital of Cisanello, Via Paradisa 2, 56100 Pisa, Italy
    Transplantation 78:1488-95. 2004
    ..Hepatitis C virus (HCV) recurrence in HCV+ liver transplant recipients is almost inevitable and may be promoted by immunosuppression. We compared the amount of liver damage with regard to usage of steroids and basiliximab...
  94. ncbi Kaposi's sarcoma in transplant and HIV-infected patients: an epidemiologic study in Italy and France
    Diego Serraino
    Dip Epidemiologia, INMI L Spallanzani, Rome, Italy
    Transplantation 80:1699-704. 2005
    ..A follow-up study was conducted in Italy and in France to compare the epidemiology of Kaposi's sarcoma (KS) between human immunodeficiency virus (HIV)-infected people and transplant recipients...
  95. ncbi HLA-DRB1 donor-recipient mismatch affects the outcome of hepatitis C disease recurrence after liver transplantation
    Luca Saverio Belli
    Department of Gastroenterology and Hepatology, Crespi Ospedale Niguarda, Milan, Italy
    Gastroenterology 130:695-702. 2006
    ....
  96. ncbi A randomized study on Peg-interferon alfa-2a with or without ribavirin in liver transplant recipients with recurrent hepatitis C
    Mario Angelico
    Hepatology Unit, Tor Vergata University, Rome, Italy
    J Hepatol 46:1009-17. 2007
    ..We performed a randomized trial on pegylated interferon alfa-2a (Peg-IFNalpha) monotherapy vs Peg-IFNalpha and ribavirin in non-cirrhotic liver transplant recipients with recurrent hepatitis C...
  97. ncbi Liver transplantation for HCV cirrhosis: improved survival in recent years and increased severity of recurrent disease in female recipients: results of a long term retrospective study
    Luca S Belli
    Hepatology and Abdominal Organ Transplantation Unit, Niguarda Hospital, Milan, Italy
    Liver Transpl 13:733-40. 2007
    ..The combination of a female recipient receiving an older graft emerged as a strong risk factor for a severe recurrence...
  98. ncbi A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis
    Stuart J Forbes
    Hepatology Section, Department of Medicine, Imperial College, London, England
    Gastroenterology 126:955-63. 2004
    ....
  99. ncbi Incidence of second primary cancer in transplanted patients
    Emanuela Taioli
    University of Pittsburgh Cancer Institute, PA 15232, USA
    Transplantation 81:982-5. 2006
    ..However, the incidence of a second primary cancer in transplanted patients has never been studied, despite the fact that the presence of regular follow-ups and the increased survival of these patients make them a very attractive model...
  100. ncbi Normal cortical regional cerebral blood flow justifies the normal neuropsychological performance in patients with cholestatic liver disease
    Marco Senzolo
    Psychiatry Clin Neurosci 61:209-10. 2007